Yao Li
- Biochemistry top 2%
- Cancer Research top 5%
- MicroRNA in disease regulation 9
- Cancer-related molecular mechanisms research 7
- Pharmacology top 2%
- Molecular Medicine top 5%
-
- Organic Electronics and Photovoltaics 6
- Perovskite Materials and Applications 4
-
- Cancer Immunotherapy and Biomarkers 6
-
- Conducting polymers and applications 4
-
- Protein Degradation and Inhibitors 4
-
- Immune cells in cancer 4
Yao Li
68 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Biochemistry 234
- Cancer Research 409
- Complementary and alternative medicine 215
- Pharmacology 197
- Molecular Medicine 96
Countries citing papers authored by Yao Li
This map shows the geographic impact of Yao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yao Li more than expected).
Fields of papers citing papers by Yao Li
This network shows the impact of papers produced by Yao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yao Li. The network helps show where Yao Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yao Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 1 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 15 | |
| 10 | 2024 | 2 | |
| 11 | 2024 | 0 | |
| 12 | 2023 | 1 | |
| 13 | 2023 | 6 | |
| 14 | 2021 | 34 | |
| 15 | 2020 | 115 | |
| 16 | 2019 | 36 | |
| 17 | 2019 | 6 | |
| 18 | 2016 | 2 | |
| 19 | To investigate the regular of pulmonary artery pressure,heart internal diameters and heart failure during the neonatal pneumonia | 2011 | 1 |
| 20 | [As2O3 induces demethylation and up-regulates transcription of SHP-1 gene in human lymphoma cell line T2 cells]. | 2009 | 1 |
About Yao Li
Yao Li is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 77 papers that have together received 2.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (7 papers), Organic Electronics and Photovoltaics (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Perovskite Materials and Applications (4 papers), Conducting polymers and applications (4 papers), Protein Degradation and Inhibitors (4 papers) and Immune cells in cancer (4 papers). The work is most often cited by research in Biochemistry (234 citations), Cancer Research (409 citations) and Complementary and alternative medicine (215 citations). Yao Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Shengnan Wang, Jiaying Yao, Chunyan Han, Jiaxin Yang, Maria Chaudhry, Yulong Yin, Hongnan Liu, Meng-Ning Wei, Zhi Shi and Zihao Xing. Their work appears in journals such as Advanced Materials, Angewandte Chemie International Edition and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.